E-LIB Suche - Ergebnisse für: Kongnakorn, T.

1

EE454 Cost-Effectiveness of Screening for Atrial Fibrillati..:

Subash, R. ; Kongnakorn, T. ; Jhanjee, R..
Value in Health. 26 (2023) 6 - p. S142 , 2023

Link: https://doi.org/10.1016/..

2

MSR149 Cost-Effectiveness Model Conceptualisation in Chroni..:

Elisheva, L. ; Abdul Jabbar, O.A. ; Kongnakorn, T....
Value in Health. 26 (2023) 12 - p. S422 , 2023

Link: https://doi.org/10.1016/..

3

EE27 Cost-Effectiveness and Cost-Utility Analysis of Somatr..:

Rivolo, S ; Loftus, J ; Peter, B...
Value in Health. 25 (2022) 12 - p. S58 , 2022

Link: https://doi.org/10.1016/..

4

P37 The Cure Myth: Experience from Recent Health Technology..:

Mohseninejad, L ; Hardy, A ; Westley, T.
Value in Health. 25 (2022) 1 - p. S8 , 2022

Link: https://doi.org/10.1016/..

5

Cost-effectiveness of apixaban versus other oral anticoagul..:

Kulkarni, N ; Taur, S ; Tichy, E..
European Heart Journal. 43 (2022) Supplement_1 - p. , 2022

Link: https://doi.org/10.1093/..

6

PCN130 Modeling Approaches in Cost-Effectiveness Analysis (..:

Kongnakorn, T. ; Walker, A. ; Sarri, G....
Value in Health. 23 (2020) - p. S446 , 2020

Link: https://doi.org/10.1016/..

7

PCN426 WHEN CROSS-OVER ISN'T CROSS OVER. STRATEGIES FOR HAN..:

Chapman, R. ; Kongnakorn, T.
Value in Health. 22 (2019) - p. S518 , 2019

Link: https://doi.org/10.1016/..

8

Budget Impact Of Introducing Ceftazidime-Avibactam (CAZ-AVI..:

Kongnakorn, T ; Tichy, E ; Merinopoulou, E...
Value in Health. 20 (2017) 9 - p. A782 , 2017

Link: https://doi.org/10.1016/..

9

Cost-Minimization Analysis in Postoperative Pain Management..:

Barra, M ; Remak, E ; Liu, D...
Value in Health. 19 (2016) 7 - p. A882 , 2016

Link: https://doi.org/10.1016/..

10

Improvement of Long Term Risks of Cardiovascular Events Ass..:

Yang, L ; Cai, M ; Ma, M...
Value in Health. 19 (2016) 7 - p. A863-A864 , 2016

Link: https://doi.org/10.1016/..

11

Value And Cost Conundrum In Advanced Oncology: Integration ..:

Ambavane, A ; Benedict, A ; Lanitis, T.
Value in Health. 19 (2016) 7 - p. A399 , 2016

Link: https://doi.org/10.1016/..

12

Challenges In Economic Evaluation of Antibiotics In Health-..:

Chapman, R ; Kongnakorn, T
Value in Health. 18 (2015) 7 - p. A580 , 2015

Link: https://doi.org/10.1016/..

13

Estimating The Lifetime Clinical Risk/Benefits of Apixaban ..:

Phatak, H. ; Dorian, P. ; Kongnakorn, T....
Value in Health. 18 (2015) 3 - p. A131 , 2015

Link: https://doi.org/10.1016/..

14

Cost-effectiveness of apixaban vs. current standard of care..:

Dorian, P. ; Kongnakorn, T. ; Phatak, H....
European Heart Journal. 35 (2014) 28 - p. 1897-1906 , 2014

Link: https://doi.org/10.1093/..

15

Validation Of The Apixaban Cost-Effectiveness Model In Pati..:

Kachroo, S. ; Phatak, H. ; Dorian, P....
Value in Health. 17 (2014) 3 - p. A113 , 2014

Link: https://doi.org/10.1016/..